Ivermectin–Fenbendazole Interaction
No specific drug–drug interaction between ivermectin and fenbendazole is established as a clinically relevant pharmacokinetic interaction in humans or animals. [6]
The main practical interaction when both are used in the same parasite-control program is on anthelmintic selection pressure and treatment efficacy/resistance management, not acute toxicity from a direct interaction. [17]
Pharmacokinetic and Metabolic Interaction Considerations
Ivermectin is metabolized by human cytochrome P450 enzymes, with CYP3A4 identified as a primary enzyme, which supports the possibility of drug-interaction risk with strong CYP3A4 modulators rather than with fenbendazole specifically. [12, 6]
Review-level pharmacology literature describes ivermectin interactions largely in the context of other substrates/inhibitors affecting P450 and transporters, and it does not identify a characteristic interaction specifically with fenbendazole. [6, 7]
Anthelmintic Strategy Interaction (Efficacy)
Studies in grazing cattle have evaluated the use of ivermectin plus fenbendazole as a combined strategy against gastrointestinal nematodes rather than reporting antagonism from a drug–drug interaction. [3]
In an Ontario cow-calf herd study comparing fenbendazole and ivermectin, treatment outcomes showed minimal difference between the two anthelmintics, supporting that the drugs can be used as alternatives rather than requiring special interaction management. [4]
Anthelmintic Strategy Interaction (Resistance)
Using multiple anthelmintic classes can change resistance dynamics by altering selection pressure, and resistance management recommendations emphasize avoiding unnecessary or repeated whole-herd deworming without diagnostics or targeted treatment. [17, 1]
In equine nematodes, resistance to both ivermectin and fenbendazole has been documented at high prevalence depending on drug and setting, which affects how either drug performs when used in the presence of resistant parasite populations. [2]
Practical Clinical Implications
Coadministration or sequential use of ivermectin and fenbendazole is primarily an issue of whether the regimen matches the suspected parasite species and resistance profile rather than a known hazardous pharmacologic interaction. [17, 4]
Testing for anthelmintic effectiveness using fecal egg count reduction approaches and using targeted or diagnostic-driven treatment strategies are used to guide whether either class remains effective. [1, 2]
Key Evidence for Combination Use in Livestock
A field study in finishing heifers found that a fenbendazole oral drench added to ivermectin pour-on reduced parasite burden and improved performance versus endectocide-only treatment, supporting additive or complementary efficacy rather than antagonism. [3]
A survey of parasite-control practices in ranched bison reported frequent use of both macrocyclic lactones (including ivermectin) and benzimidazoles (including fenbendazole), including instances of multiple dewormers administered simultaneously, highlighting that “interaction” in practice often refers to resistance-control strategy. [1]
Common Misinterpretation: “Interaction” vs “Compatibility”
The term “interaction” is often used by practitioners to describe resistance-management consequences of using two anthelmintics in the same program. [17, 1]
A direct pharmacologic incompatibility causing acute toxicity from combining ivermectin with fenbendazole is not supported by the cited pharmacology and veterinary field-efficacy literature. [6, 3]
End of interaction summary.